Page last updated: 2024-09-04

tipifarnib and sesquiterpenes

tipifarnib has been researched along with sesquiterpenes in 3 studies

Compound Research Comparison

Studies (tipifarnib)	Trials (tipifarnib)	Recent Studies (post-2010) (tipifarnib)	Studies (sesquiterpenes)	Trials (sesquiterpenes)	Recent Studies (post-2010) (sesquiterpenes)
309	92	94	17,489	536	7,668

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sánchez De Cos Escuín, J	1
Filov, VA; Gershanovich, ML; Imianitov, EN; Stukov, AN	1
Beese, LS; Hast, MA; Hellinga, HW; Lubock, NB; Mabanglo, MF	1

Reviews

2 review(s) available for tipifarnib and sesquiterpenes

Article	Year
[New therapeutic targets and strategies in lung cancer]. Archivos de bronconeumologia, 2002, Volume: 38, Issue:8 Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2002
[Problems in the current target therapy of malignancies]. Voprosy onkologii, 2005, Volume: 51, Issue:5 Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab	2005

Article

Year

[New therapeutic targets and strategies in lung cancer].

Archivos de bronconeumologia, 2002, Volume: 38, Issue:8

Topics: Alkyl and Aryl Transferases; Angiogenesis Inhibitors; Antineoplastic Agents; Benzamides; Benzodiazepines; Clinical Trials as Topic; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Endothelial Growth Factors; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Erlotinib Hydrochloride; Farnesyltranstransferase; Gefitinib; Humans; Imatinib Mesylate; Imidazoles; Intercellular Signaling Peptides and Proteins; Lung Neoplasms; Lymphokines; Metalloendopeptidases; Multicenter Studies as Topic; Piperazines; Polyisoprenyl Phosphates; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Quinolones; Randomized Controlled Trials as Topic; Receptor Protein-Tyrosine Kinases; Sesquiterpenes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors

2002

[Problems in the current target therapy of malignancies].

Voprosy onkologii, 2005, Volume: 51, Issue:5

Topics: Alemtuzumab; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antineoplastic Agents; Azathioprine; Benzamides; Bevacizumab; Cetuximab; Erlotinib Hydrochloride; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Phthalazines; Piperazines; Pyridines; Pyrimidines; Quinazolines; Quinolones; Rituximab; Sesquiterpenes; Sesquiterpenes, Guaiane; Trastuzumab

2005

Other Studies

1 other study(ies) available for tipifarnib and sesquiterpenes

Article	Year
Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design. Protein science : a publication of the Protein Society, 2014, Volume: 23, Issue:3 Topics: Antifungal Agents; Aspergillus fumigatus; Benzenesulfonamides; Catalytic Domain; Crystallography, X-Ray; Drug Design; Farnesyltranstransferase; Fungal Proteins; Humans; Peptides; Polyisoprenyl Phosphates; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolones; Sesquiterpenes; Sulfonamides	2014

Article

Year

Crystal structures of the fungal pathogen Aspergillus fumigatus protein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug design.

Protein science : a publication of the Protein Society, 2014, Volume: 23, Issue:3

Topics: Antifungal Agents; Aspergillus fumigatus; Benzenesulfonamides; Catalytic Domain; Crystallography, X-Ray; Drug Design; Farnesyltranstransferase; Fungal Proteins; Humans; Peptides; Polyisoprenyl Phosphates; Protein Conformation; Protein Structure, Secondary; Protein Structure, Tertiary; Quinolones; Sesquiterpenes; Sulfonamides

2014